Zydus Wellness

    ZYDUSWELL
    FMCG
    ₹456.60
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹14,527 Cr

    P/E
    58.99
    Day range
    ₹455.45 – ₹464.20
    52-week range
    ₹367.55 – ₹611.85
    Volume
    55,448
    Open
    ₹462.65
    Prev close
    ₹460.35

    Latest results · Q2 FY27(consolidated)Revenue ₹1,127 Cr+73.2%Profit ₹5 CrMargin 0.5%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 44 / 100

    Factor percentiles

    Value47
    Quality22
    Momentum44
    Low volatility66

    Derived metrics

    Earn. yield
    1.7%
    Graham no.
    ₹181.04
    vs Graham
    -60.3%
    ROE ÷ P/B
    1.4%
    12-1 mom.
    +13.2%
    Return / vol
    0.06
    Magic Formula
    #587
    Piotroski
    3/6
    FCF yield
    0.9%

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 45 in FMCG
    Largest FMCG companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Hindustan UnileverHINDUNILVR₹4.68 L Cr44.259.5830.7%28.0%22.0%0.03+14.5%
    ITCITC₹3.72 L Cr19.685.1829.5%39.0%28.0%0.01+3.9%
    Nestle IndiaNESTLEIND₹2.47 L Cr60.6043.2376.3%85.0%24.0%0.08+20.3%
    Varun BeveragesVBL₹1.44 L Cr146.907.4316.9%20.0%22.0%0.13+33.2%
    MaricoMARICO₹1.18 L Cr58.2325.1144.3%47.0%18.0%0.26+13.0%
    Britannia IndustriesBRITANNIA₹1.13 L Cr42.1526.9953.6%56.0%18.0%0.62+15.6%
    Tata Consumer ProductsTATACONSUM₹1.12 L Cr65.864.997.4%9.0%14.0%0.11+14.0%
    Zydus WellnessZYDUSWELL₹14,527 Cr58.992.473.4%5.0%7.6%0.54+73.2%
    Sector median₹14,559 Cr34.445.4818.1%19.0%15.0%0.20+14.8%

    Sector as classified in the tracked universe; medians use every tracked FMCG company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 5h ago

    Headlines about Zydus Wellness from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    58.3
    Price / Book
    2.45
    ROE (FY26)
    3.4%
    ROCE (latest year)
    5%
    Dividend yield
    0.26%

    Moving averages (NSE)

    20-day
    ₹475.52
    Price below
    50-day
    ₹504.14
    Price below
    200-day
    ₹493.26
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +20.7%
    Profit 3Y CAGR
    -14.0%
    Revenue YoY (Sep 2026)
    +73.2%
    Operating margin
    7.6%
    Net margin
    0.5%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    -500 Cr0 Cr500 Cr1K Cr1.5K Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%15%30%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • DII
    • Public
    • FII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-5K Cr-2.5K Cr0 Cr2.5K Cr5K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%10%20%30%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr2K Cr4K Cr6K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 20260x0.5x1x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date. Not adjusted for the split of 18 Sept 2025: earlier bars are per pre-split share.

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26₹0₹2.5₹5₹7.5₹10

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales403.20782.60841492.90461.90913.10860.90650.50964.901,484.701,4371,126.60
    YoY Sales growth-3.17———————————
    Expenses390.50620.40685.70473.30447.10723.10705.30627.50903.901,214.601,195.301,041.10
    Operating Profit12.70162.20155.3019.6014.80190155.602361270.10241.7085.50
    OPM %3.1%20.7%18.5%4.0%3.2%20.8%18.1%3.5%6.3%18.2%16.8%7.6%
    Other Income3.40459.903.800.803-32.80-5.801.203.806.40
    Interest6.306.103.600.903.304.202.5015.7041.2038.7026.3027.20
    Depreciation6.105.705.104.905.2013.2010.8025.1055.5055.3057.1057.10
    Profit before tax3.70154.40151.6023.7010.10173.40145.30-50.60-41.50177.30162.107.60
    Tax %91.9%2.7%2.6%11.8%36.6%0.9%12.0%4.3%-3.9%8.6%26.6%32.9%
    Net Profit0.30150.30147.7020.906.40171.90127.90-52.80-39.90162118.905.10
    EPS in Rs₹0.01₹4.72₹4.64₹0.66₹0.20₹5.40₹4.02₹-1.66₹-1.25₹5.09₹3.74₹0.16

    From company filings, updated 18 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days35

    +17 days since Mar 2021

    Inventory Days178

    +20 days since Mar 2021

    Days Payable107

    -82 days since Mar 2021

    Cash Conversion Cycle106

    +119 days since Mar 2021

    Working Capital Days48

    +83 days since Mar 2021

    Strengths, risks & growth

    Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)

    Strengths

    • Company is expected to give good quarter

    Risks

    • Company has a low return on equity of 5.09% over last 3 years.
    • Dividend payout has been low at 14.1% of profits over last 3 years

    Compounded Sales Growth

    10 Years
    +26%
    5 Years
    +16%
    3 Years
    +21%
    TTM
    +74%

    Compounded Profit Growth

    10 Years
    +8%
    5 Years
    -2%
    3 Years
    -10%
    TTM
    -11%

    Stock Price CAGR

    10 Years
    +10%
    5 Years
    +3%
    3 Years
    +14%
    1 Year
    +1%

    Return on Equity

    10 Years
    +6%
    5 Years
    +6%
    3 Years
    +5%
    Last Year
    +4%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter69.64%69.64%69.63%69.63%0.00 pp
    FII3.27%3.17%3.32%3.57%+0.25 pp
    DII18.58%18.87%19.13%19.39%+0.26 pp
    Public8.51%8.32%7.92%7.42%-0.50 pp

    Filed with NSE for Sept 2026: promoters 69.64%, public 30.36%

    Analysts & fund holdings

    100%
    100% recommend buy
    8 analysts cover the stock
    Valuation vs Food Products
    P/E59.0 vs 36.7
    Sector P/B7.35
    Beta0.38

    Who holds the shares, quarter by quarter

    Mutual funds 18.72% (-0.01 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters69.6%
    • Foreign institutions3.6%
    • Mutual funds18.7%
    • Insurance0.6%
    • Other domestic institutions0.1%
    • Retail5.2%
    • Others2.2%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Parag Parikh Flexi Cap Fund6.92%0.70%-0.16 pp
    Nippon India Small Cap Fund5.41%1.03%-0.22 pp
    Quant Small Cap Fund2.84%1.23%-0.30 pp
    Quant Multi Cap Fund0.55%1.08%-0.18 pp
    Bajaj Finserv Small Cap Fund0.51%2.69%-0.33 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 291 daily sessions to 17 Nov 2026. Adjusted for 1 corporate action.

    Computed

    Risk

    Volatility (1Y)
    38.1%
    Downside volatility
    34.0%
    Worst 5% of days
    3.6%
    Average of that tail
    4.3%
    Max drawdown (1Y)
    28.8%
    Below its peak
    23.6%

    Against the market

    Beta vs Nifty 50
    0.54
    Correlation
    0.19
    Relative strength (3M)
    -14.0%
    ATR (14)
    4.0%

    Return

    Return 1M
    -9.7%
    Return 3M
    -9.8%
    Return 6M
    -8.3%
    Return 1Y
    +2.2%
    vs 200-day average
    -6.7%

    Momentum

    RSI (14)
    39.3
    MACD histogram
    0.07
    Stochastic %K
    6.1
    ADX (14)
    17.0
    +DI / −DI
    15.0 / 20.4
    Money flow index
    77.4

    Participation

    Delivery (20d avg)
    41.0%
    vs its 60-day baseline
    -1.7 pts
    Volume vs 20-day
    -0.3σ
    Close vs day's VWAP
    -0.5%
    52-week position
    38 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    Piotroski F-Score

    3 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — failed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — failed
    • Current ratio improving — passed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — failed
    • Asset turnover improving — passed
    Free cash flow
    ₹125 Cr
    FCF yield
    0.9%
    Cash conversion
    1.15
    Accruals ratio
    -0.003
    Net debt
    ₹3,131 Cr
    Net debt / equity
    0.53
    EV / sales
    3.55
    Capex intensity
    2.6%
    Revenue CAGR
    15.0%
    Profit CAGR
    -90.4%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Insider trades

    Last 12 months, market trades
    Net buying ₹66.4 L
    12 buys · ₹67.4 L
    1 sells · ₹1.0 L
    Latest insider trades disclosed to NSE
    PersonTypeSharesValueDisclosed
    Prashant Babubhai Patel
    Promoter Group · Off Market
    Buy27,250₹024 Aug 2026
    Rinesh Gajjar
    Employees/Designated Employees · Market Purchase
    Buy1,500₹6.0 L18 Mar 2026
    Rajat Bhargava
    Employees/Designated Employees · Market Purchase
    Buy750₹2.9 L9 Mar 2026
    Vineet Shrivastava
    Employees/Designated Employees · Market Purchase
    Buy787₹3.0 L9 Mar 2026
    Yatin Desai
    Employees/Designated Employees · Market Purchase
    Buy500₹1.9 L9 Mar 2026
    Punit Adhia
    Employees/Designated Employees · Market Purchase
    Buy300₹1.1 L6 Mar 2026
    Umesh Vinodray Parikh
    Key Managerial Personnel · Market Purchase
    Buy250₹95,0193 Mar 2026
    Vineet Shrivastava
    Employees/Designated Employees · Market Purchase
    Buy507₹2.0 L2 Mar 2026
    Umesh Vinodray Parikh
    Employees/Designated Employees · Market Purchase
    Buy6,225₹25.0 L17 Feb 2026
    Tarun G Arora
    Employees/Designated Employees · Market Purchase
    Buy4,000₹16.3 L16 Feb 2026
    Nidhi Punit Adhia
    Employees/Designated Employees · Market Purchase
    Buy1,000₹3.9 L10 Feb 2026
    Dhaval Narendra Soni HUF
    Other · Market Sale
    Sell250₹1.0 L9 Dec 2025

    Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.

    Corporate actions

    • dividend
      Not available — not reported in this filing

      Dividend - Re 1.20 Per Share

      17 Jul 2026
      ex-date
    • split
      Not available — not reported in this filing

      Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

      18 Sept 2025
      ex-date
    • dividend
      ₹6.00

      Dividend - Rs 6 Per Share

      11 Jul 2025
      ex-date
    • dividend
      ₹5.00

      Dividend - Rs 5 Per Share

      19 Jul 2024
      ex-date
    • dividend
      ₹5.00

      Dividend - Rs 5 Per Share

      21 Jul 2023
      ex-date
    • dividend
      ₹5.00

      Dividend - Rs 5 Per Share

      14 Jul 2022
      ex-date
    • dividend
      ₹5.00

      Annual General Meeting/Dividend - Rs 5 Per Share

      14 Jul 2021
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      12 Aug 2020
      ex-date
    • dividend
      ₹5.00

      Interim Dividend - Rs 5 Per Share

      19 Mar 2020
      ex-date
    • dividend
      ₹5.00

      Dividend - Rs 5 Per Share

      17 Jul 2019
      ex-date
    • dividend
      ₹8.00

      Dividend- Rs 8 Per Share

      18 Jul 2018
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      27 Jul 2017
      ex-date
    • dividend
      Not available — not reported in this filing

      Interim Dividend Re 6.50 Per Share (Purpose Revised)

      9 Mar 2017
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      21 Jul 2016
      ex-date
    • dividend
      ₹6.50

      Interim Dividend - Rs 6.50/- Per Share

      16 Mar 2016
      ex-date
    • dividend
      ₹6.00

      Annual General Meeting/Dividend - Rs 6/- Per Share

      16 Jul 2015
      ex-date
    • dividend
      ₹6.00

      Annual General Meeting / Dividend - Rs 6/- Per Share

      3 Jul 2014
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      22 Jul 2013
      ex-date
    • dividend
      ₹6.00

      Interim Dividend @ Rs. 6/- Per Equity Share

      22 May 2013
      ex-date
    • dividend
      ₹5.00

      Annual General Meeting/Dividend Rs 5 Per Share

      18 Jul 2012
      ex-date

    Company announcements

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper publication

    Insider Trading / SAST
    Closure of Trading Window

    Trading Window Closure for the quarter and half year ending on September 30, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Change in Management

    Change in Senior Management Personnel

    Company Update
    Clarification On Volume Movement

    Clarification on volume movement

    Company UpdatePrice-sensitive
    Clarification sought from Zydus Wellness Ltd

    The Exchange has sought clarification from Zydus Wellness Ltd on September 8, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.

    Company Update
    ESG Rating Assigned By SES

    ESG rating assigned by SES

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Analyst / Institutional Investors' Conference on September 22, 2026

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Transcript of 32nd Annual General Meeting

    Company Update
    Announcement under Regulation 30 (LODR)-Change in Management

    Appointment of Mr. Kapil Sharma as Chief Revenue Officer forming part of Senior Management of the Company

    Company Update
    Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

    Disclosure under SEBI (PIT) Regulations, 2015

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Credit Rating

    Credit rating assigned by Care Ratings Limited

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Transcript of the Earnings Conference call held on August 4, 2026

    Company Update
    ESG Rating

    ESG rating received from Crisil

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analyst / Institutional Investors' Conference to be held on August 14, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper publication regarding unaudited financial results for the quarter ended on June 30, 2026

    Filed with BSE (scrip 531335); the last 45 days. Documents open at bseindia.com.

    Documents

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 3 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Zydus Wellness: common questions

    Answered from the figures on this page.

    Zydus Wellness last traded at ₹456.60 (NSE, as of 18 Nov 2026). The last session moved it down 0.81%.

    Zydus Wellness is valued at about ₹14,527 crore (NSE, as of 18 Nov 2026).

    Zydus Wellness trades at a price-to-earnings ratio of 58.99 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Zydus Wellness has traded between ₹367.55 and ₹611.85 over the past 52 weeks, to 18 Nov 2026. It is currently 36% of the way up that range.

    Zydus Wellness (ZYDUSWELL) is classified under FMCG on this site's screener.